The S&P/ASX 200 Index (ASX: XJO) is enjoying a strong week, up 2.2% in afternoon trade on Friday, with three ASX 200 stocks doing more than their share of the lifting.
The laggard of the pack has gained 14% since last Friday's close, while the leader is up a whopping 33%.
In one week.
So, which hot stocks are we talking about?
Read on!
(Note, with several hours of trade left in the week, the best-performing share list could still move by market close, with some close contenders for the number three spot at the time of writing.)
Three ASX 200 stocks going gangbusters this week
Starting with the third-best-performing ASX 200 stock on our list, we have Tabcorp Holdings Ltd (ASX: TAH).
Shares in the ASX gambling company closed last Friday trading for 45.5 cents. Shares are currently up 2.0% on Friday, changing hands for 52.0 cents apiece. That sees the Tabcorp share price up 14.3% over the week. Shares remain down 36% over 12 months.
Tabcorp shares also trade on a partly franked trailing dividend yield of 2.5%.
With no fresh price-sensitive news from the company, investors may believe the stock has been oversold, given the Aussie economy's good performance and the prospect of lower interest rates in 2025.
Moving on to the second-best ASX 200 stock performer of the week, we have Sigma Healthcare Ltd (ASX: SIG).
Shares in the pharmacy chain operator and distributor closed last Friday at $1.96. At the time of writing today, they are up 7.8% and trading for $2.595 each. That puts the Sigma Healthcare share price up a very impressive 32.4% over the week.
The ASX healthcare stock is now up a whopping 293% in a year. Sigma shares also trade on a slender 0.4% on a partly franked trailing dividend yield.
The lion's share of this week's gains was delivered on Thursday when the Sigma share price closed up 24.9%.
That huge leap came after the company announced that the Australian Competition & Consumer Commission (ACCC) won't oppose its planned merger with Chemist Warehouse.
Which brings us to the top ASX 200 stock performer of the week, Neuren Pharmaceuticals Ltd (ASX: NEU).
Shares in the biopharma company closed on Friday at $12.25. At the time of writing, shares are swapping hands for $15.40 apiece, up 13.9% in intraday trade. That sees the Neuren share price up a very impressive 33.8% since last Friday's close.
Neuren shares are up 26% over 12 months. Neuren does not pay dividends at this time.
Spurring investor interest this week, the ASX 200 stock announced on Wednesday that it will receive a lump sum payment of some US$50 million (AU$76 million) from its United States partner, Acadia Pharmaceuticals.
Investors have also reacted positively to Neuren's third-quarter trading update, which was released on Thursday.
